New drug hopes to calm skin lupus flares
NCT ID NCT05629208
First seen Jan 12, 2026 · Last updated May 18, 2026 · Updated 18 times
Summary
This study tested an experimental drug called GS-5718 for people with cutaneous lupus erythematosus (CLE), a condition that causes painful skin rashes and sores. Researchers wanted to see if the drug could reduce skin disease activity and improve symptoms. The study was stopped early, but the goal was to find a safer, more effective treatment for CLE.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ARENSIA Exploratory Medicine, LLC
Phoenix, Arizona, 85015, United States
-
Center for Dermatology Clinical Research Inc.
Fremont, California, 94538, United States
-
Clinical Investigations of Texas
Plano, Texas, 75075, United States
-
Clinical Research of West Florida, Inc.
Clearwater, Florida, 33765, United States
-
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, 46250, United States
-
Dept. of Dermatology, Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine (PCAM)
Philadelphia, Pennsylvania, 19104, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30303, United States
-
Gulf Bank Medical Center
Houston, Texas, 77037, United States
-
HMD Research LLC
Orlando, Florida, 32819, United States
-
Hospital General de Granollers
Granollers, 08402, Spain
-
Hospital Universitario de Navarra
Pamplona, 31008, Spain
-
Reliant Medical Research
Miami, Florida, 33165, United States
-
Universitatsklinikum Freiburg Klinik fur Dermatologie und Venerologie
Freiburg im Breisgau, 79104, Germany
-
University of Colorado, Barbara Davis Center, Center for Clinical Research
Aurora, Colorado, 80045, United States
-
Universitätsklinikum Carl Gustav Carus Klinik und Poliklinik für Dermatologie
Dresden, 01307, Germany
-
Universitätsklinikum Leipzig AöR Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie Klinische Forschungseinheit (KFE) - Haus 10
Leipzig, 04103, Germany
-
Yale Center for Clinical Investigation (YCCI)
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.